Andrea Loewen - Net Worth and Insider Trading

Andrea Loewen Net Worth

The estimated net worth of Andrea Loewen is at least $5 Million dollars as of 2024-11-13. Andrea Loewen is the SVP, Global Regulatory Affairs of Reata Pharmaceuticals Inc and owns about 28,416 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $5 Million. Details can be seen in Andrea Loewen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrea Loewen has not made any transactions after 2023-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrea Loewen

To

Andrea Loewen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrea Loewen owns 2 companies in total, including Immunic Inc (IMUX) , and Reata Pharmaceuticals Inc (RETA) .

Click here to see the complete history of Andrea Loewen’s form 4 insider trades.

Insider Ownership Summary of Andrea Loewen

Ticker Comapny Transaction Date Type of Owner
IMUX Immunic Inc 2014-04-16 See Remarks
RETA Reata Pharmaceuticals Inc 2023-09-26 SVP & Global Regulatory Affairs

Andrea Loewen Latest Holdings Summary

Andrea Loewen currently owns a total of 1 stock. Andrea Loewen owns 28,416 shares of Reata Pharmaceuticals Inc (RETA) as of September 14, 2023, with a value of $5 Million.

Latest Holdings of Andrea Loewen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RETA Reata Pharmaceuticals Inc 2023-09-14 28,416 172.36 4,897,782

Holding Weightings of Andrea Loewen


Andrea Loewen Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrea Loewen has made a total of 4 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 3,175 shares on September 14, 2023, which brought Andrea Loewen around $546,195.

Insider Trading History of Andrea Loewen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrea Loewen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrea Loewen Ownership Network

Ownership Network List of Andrea Loewen

No Data

Ownership Network Relation of Andrea Loewen

Insider Network Chart

Andrea Loewen Owned Company Details

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Andrea Loewen is the See Remarks of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Andrea Loewen made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunic Inc Insider Transactions

No Available Data

Andrea Loewen Mailing Address

Above is the net worth, insider trading, and ownership report for Andrea Loewen. You might contact Andrea Loewen via mailing address: C/o Vital Therapies, Inc., 15010 Avenue Of Science, Suite 200, San Diego Ca 92128.